Skip to main content
. 2017 Nov 28;8:1816. doi: 10.1038/s41467-017-01968-5

Fig. 5.

Fig. 5

A summary of the status of the 11 patients in the pilot trial (a) and 16 patients in the contemporaneous cohort (b). In the SOC group, 14 of 16 have progressed radiographically compared to 1 of 11 in the adaptive therapy cohort. Cumulative dose of abiraterone in the adaptive therapy patients was 47% of SOC